Metabolic mapping of A3 adenosine receptor agonist MRS5980
Graphical abstract
Introduction
Drug efficiency, toxicity, and metabolic elimination are the major properties determining whether a drug candidate can successfully enter clinical trials [1]. Through combining in vitro incubation mixtures and in vivo animal models, the metabolic pathways of drugs and drug candidates have been elucidated, such as ifosfamide [2], noscapine [3] and aryl hydrocarbon receptor antagonist GNF-351 [4]. Metabolomics can be used to phenotype the alteration of endogenous substances, which can directly reflect the disruption of metabolic pathways by a drug and serve as biomarkers for efficacy and toxicity. For example, serum metabolomics was employed to explain the adverse effects of gemfibrozil through analyzing the alteration of lysophosphatidylcholine and bile acid components in gemfibrozil-treated mice [5].
The A3 adenosine receptor (AR), a G protein-coupled receptor, is a therapeutic target for many diseases (e.g., hepatocellular carcinoma, autoimmune inflammatory diseases, chronic neuropathic pain, etc.), and development of A3AR selective agonists as drug candidates has been a major goal to treat these diseases [6], [7]. (1S,2R,3S,4R,5S)-4-(2-((5-Chlorothiophen-2-yl)ethynyl)-6-(methylamino)-9H-purin-9-yl)-2,3-dihydroxy-N-methylbicyclo[3.1.0]hexane-1-carboxamide (MRS5980) is a recently developed A3AR selective agonist that contains multiple receptor affinity- and selectivity-enhancing modifications [8]. This nucleoside derivative contains a rigid ribose carbocyclic substitution ([3.1.0]bicyclohexane) that maintains a receptor-preferred conformation. The 2-arylethynyl substituent of sterically constrained nucleoside analogues is predicted to induce an adjustment of the position of the second transmembrane helical domain of the A3AR, which contributes to its lack of affinity at the A2AAR [8]. The present study used metabolomics to evaluate MRS5980 metabolism and interactions, including the metabolic elimination of MRS5980, electrophilic reactivity and influence on lipid profiles of MRS5980 in the body.
Section snippets
Chemicals and reagents
MRS5980 was synthesized as described [8]. β-Nicotinamide adenine dinucleotide 2′-phosphate reduced tetrasodium salt (NADPH) and reduced glutathione were purchased from Sigma-Aldrich (St. Louis, MO). All other reagents were of the highest grade commercially available. Livers from untreated 6- to 8-week-old male C57BL/6J mice were used to prepare mouse liver microsomes (MLMs) as previously described [4]. Human liver microsomes (HLMs), recombinant cytochromes P450 (CYP) 1A1, 1A2, 1B1, 2A6, 2B6,
Metabolomics analysis to find biomarkers for exposure to MRS5980
The chromatographic behavior of MRS5980 showed elution at 5.6 min (Fig. 1A), and MRS5980 showed doublet m/z 459.104 and 461.102 ions (Fig. 1B). MS was performed in the positive-ion mode, because compounds containing halogens (especially chlorine and bromine) can produce very distinct isotope peaks [11]. The MS/MS spectrum of MRS5980 (m/z = 459.104) showed the major fragment ions 428 and 290, and the corresponding fragmentation patterns were also given (Fig. 1C). UPLC-ESI-QTOFMS analysis coupled
Discussion
Developing safer drugs and drug candidates has been a major goal of the pharmaceutical industry, and its importance has been intensified by the withdrawal of many drugs (e.g., Ximelagatran, Rofecoxib, Lumiracoxib, etc.) from the market and a decrease of new chemical entities (NCEs) introduced into the market [13]. In preclinical efficacy testing, in the chronic constriction injury (CCI, sciatic nerve) model in mice, the ED50 value of MRS5980 at its peak effect following oral administration was
Conflicts of interest
The authors report no conflict of interest.
Acknowledgements
This study was funded by the Intramural Research Programs of the Center for Cancer Research, National Cancer Institute and the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, the National Natural Science Foundation of China (No. 81202586), and Tianjin Project of Thousand Youth Talents.
References (27)
- et al.
Comparative metabolism of cyclophosphamide and ifosfamide in the mouse using UPLC-ESI-QTOFMS-based metabolomics
Biochem. Pharmacol.
(2010) - et al.
Intestinal CYP3A4 protects against lithocholic acid-induced hepatotoxicity in intestine-specific VDR-deficient mice
J. Lipid Res.
(2014) - et al.
Polyenephosphatidylcholine prevents alcoholic liver disease in PPARalpha-null mice through attenuation of increases in oxidative stress
J. Hepatol.
(2009) - et al.
LC–MS-based metabolomics: an update
Arch. Toxicol.
(2014) - et al.
Metabolic map and bioactivation of the anti-tumour drug noscapine
Br. J. Pharmacol.
(2012) - et al.
In vivo effects of the pure aryl hydrocarbon receptor antagonist GNF-351 after oral administration are limited to the gastrointestinal tract
Br. J. Pharmacol.
(2014) - et al.
Gemfibrozil disrupts lysophosphatidylcholine and bile acid homeostasis via PPARα and its relevance to hepatotoxicity
Arch. Toxicol.
(2014) - et al.
Rigidified A3 adenosine receptor agonists: 1-Deaza modification maintains high in vivo efficacy
ACS Med. Chem. Lett.
(2015) - et al.
The A3 adenosine receptor: history and perspectives
Pharmacol. Rev.
(2015) - et al.
In vivo phenotypic screening for treating chronic neuropathic pain: modification of C2-arylethynyl group of conformationally constrained A3 adenosine receptor agonists
J. Med. Chem.
(2014)
Metabolomics reveals trichloroacetate as a major contributor to trichloroethylene-induced metabolic alterations in mouse urine and serum
Arch. Toxicol.
Glucuronidation of the broad-spectrum antiviral drug arbidol by UGT isoforms
J. Pharm. Pharmacol.
Cytochrome P450-mediated bioactivation of the epidermal growth factor receptor inhibitor erlotinib to a reactive electrophile
Drug Metab. Dispos.
Cited by (14)
Mass spectrometry-based fecal metabolome analysis
2019, TrAC - Trends in Analytical ChemistryCitation Excerpt :This study revealed potential biomarkers in feces from AS mice and supplied a systematic view of the pathological changes in the gastrointestinal metabolites of AS mice. Analysis of metabolites in fecal samples by LC-Q-TOF MS is also frequently carried out to investigate medicine metabolism, such as amiodarone [90], polycyclic musk [91], tanshinol borneol ester [92], traditional Chinese medicines [93–100], harmane [101], icaritin and central-icaritin [102], Lappaconitine [103], agomelatine [104], A3 adenosine receptor agonist [105], phosphodiesterase type 5 inhibitor [106], and phenolic compounds [107]. Deng et al. [93] identified 66 metabolites of poliumoside in rat feces using LC-Q-TOF MS platform.
Non-targeted metabolomics-guided sildenafil metabolism study in human liver microsomes
2018, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life SciencesCitation Excerpt :LC–MS-based metabolomics in the study of xenobiotic metabolism was first proposed by Plumb et al. [18] and has been reviewed recently [3,4]. Combining this with other techniques including the introduction of stable isotopes and the use of genetically modified animals, there have been many successful efforts to identify novel drug metabolites [19–21], characterize species-dependency in drug metabolism [22], and identify metabolic pathways [23]. However, practical challenges with such metabolomics approaches still exist with regard to a lack of a confidence during drug metabolite peak selection among numerous candidate peaks.
Structural Optimization and Anticancer Activity of Polo-like Kinase 1 (Plk1) Polo-Box Domain (PBD) Inhibitors and Their Prodrugs
2023, ACS Pharmacology and Translational ScienceAdenosine A<inf>3</inf> Receptor (A<inf>3</inf>AR) Agonist for the Treatment of Bleomycin-Induced Lung Fibrosis in Mice
2022, International Journal of Molecular SciencesAntiviral drug delivery system for enhanced bioactivity, better metabolism and pharmacokinetic characteristics
2021, International Journal of NanomedicineRole of metabolic activation in elemicin-induced cellular toxicity
2019, Journal of Agricultural and Food Chemistry
- 1
Present address: College of Pharmaceutical Sciences, Shandong University, Shandong 250012, China.